AMBALAL SARABHAI ENTERPRISES
Back to All Ratios
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | 5.07 | -10.80 | -68.28 | 131.58 | 29.13 |
What is the latest Core EBITDA Growth ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | 5.07 |
| Mar2024 | -10.80 |
| Mar2023 | -68.28 |
| Mar2022 | 131.58 |
| Mar2021 | 29.13 |
How is Core EBITDA Growth of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | 5.07 | Positive | |
| Mar2024 | -10.8 | Negative | |
| Mar2023 | -68.28 | Negative | |
| Mar2022 | 131.58 | 351.70 | |
| Mar2021 | 29.13 | - | |
Other Financial Ratios of AMBALAL SARABHAI ENTERPRISES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹205.7 Cr | -3.3% | -13.7% | -53.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -3.3% |
-13.7% |
-53.8% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses